1. Home
  2. TKNO vs EIC Comparison

TKNO vs EIC Comparison

Compare TKNO & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • EIC
  • Stock Information
  • Founded
  • TKNO 1996
  • EIC N/A
  • Country
  • TKNO United States
  • EIC United States
  • Employees
  • TKNO N/A
  • EIC N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • EIC Finance/Investors Services
  • Sector
  • TKNO Health Care
  • EIC Finance
  • Exchange
  • TKNO Nasdaq
  • EIC Nasdaq
  • Market Cap
  • TKNO 256.9M
  • EIC 348.9M
  • IPO Year
  • TKNO 2021
  • EIC 2019
  • Fundamental
  • Price
  • TKNO $4.35
  • EIC $13.86
  • Analyst Decision
  • TKNO
  • EIC Strong Buy
  • Analyst Count
  • TKNO 0
  • EIC 1
  • Target Price
  • TKNO N/A
  • EIC $17.50
  • AVG Volume (30 Days)
  • TKNO 224.0K
  • EIC 234.9K
  • Earning Date
  • TKNO 08-07-2025
  • EIC 08-12-2025
  • Dividend Yield
  • TKNO N/A
  • EIC 11.24%
  • EPS Growth
  • TKNO N/A
  • EIC N/A
  • EPS
  • TKNO N/A
  • EIC 0.70
  • Revenue
  • TKNO $38,923,000.00
  • EIC $55,581,156.00
  • Revenue This Year
  • TKNO $9.52
  • EIC $37.84
  • Revenue Next Year
  • TKNO $15.20
  • EIC $23.33
  • P/E Ratio
  • TKNO N/A
  • EIC $19.94
  • Revenue Growth
  • TKNO 11.40
  • EIC 56.39
  • 52 Week Low
  • TKNO $4.00
  • EIC $12.10
  • 52 Week High
  • TKNO $10.37
  • EIC $16.71
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 43.35
  • EIC 70.39
  • Support Level
  • TKNO $4.22
  • EIC $12.10
  • Resistance Level
  • TKNO $4.94
  • EIC $13.15
  • Average True Range (ATR)
  • TKNO 0.29
  • EIC 0.18
  • MACD
  • TKNO -0.00
  • EIC 0.13
  • Stochastic Oscillator
  • TKNO 16.75
  • EIC 97.37

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About EIC Eagle Point Income Company Inc.

Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

Share on Social Networks: